非小细胞肺癌分子靶向EGFR-TKI治疗敏感性与治疗耐受性预测筛选的分子显像研究现状及进展

More than 80% of lung cancer is non-small cell lung cancer (NSCLC), and the epidermal growth factor receptor (EGFR)-mediated signaling pathway is closely related to the occurrence and development of NSCLC. Small molecule EGFR-tyrosine kinase inhibitors (EGFR-TKI) targeting EGFR have been used in the...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
综述
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973391/
https://www.ncbi.nlm.nih.gov/pubmed/29277186
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.12.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973391/
https://www.ncbi.nlm.nih.gov/pubmed/29277186
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.12.10

Ejemplares similares